Copyright Reports & Markets. All rights reserved.

Global Veterinary Pharmaceuticals Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Veterinary Pharmaceuticals by Type
    • 1.3.1 Overview: Global Veterinary Pharmaceuticals Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Veterinary Pharmaceuticals Consumption Value Market Share by Type in 2025
    • 1.3.3 Anti-Infectives
    • 1.3.4 Anti-Inflammatory
    • 1.3.5 Parasiticides
    • 1.3.6 Analgesics
    • 1.3.7 Sedatives
    • 1.3.8 Others
  • 1.4 Classification of Veterinary Pharmaceuticals by Route
    • 1.4.1 Overview: Global Veterinary Pharmaceuticals Market Size by Route: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global Veterinary Pharmaceuticals Consumption Value Market Share by Route in 2025
    • 1.4.3 Oral
    • 1.4.4 Injection
  • 1.5 Classification of Veterinary Pharmaceuticals by Control Level
    • 1.5.1 Overview: Global Veterinary Pharmaceuticals Market Size by Control Level: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global Veterinary Pharmaceuticals Consumption Value Market Share by Control Level in 2025
    • 1.5.3 Prescription-only
    • 1.5.4 OTC
  • 1.6 Global Veterinary Pharmaceuticals Market by Application
    • 1.6.1 Overview: Global Veterinary Pharmaceuticals Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Companion Animals
    • 1.6.3 Cattle
    • 1.6.4 Poultry
    • 1.6.5 Swine
    • 1.6.6 Others
  • 1.7 Global Veterinary Pharmaceuticals Market Size & Forecast
  • 1.8 Global Veterinary Pharmaceuticals Market Size and Forecast by Region
    • 1.8.1 Global Veterinary Pharmaceuticals Market Size by Region: 2021 VS 2025 VS 2032
    • 1.8.2 Global Veterinary Pharmaceuticals Market Size by Region, (2021-2032)
    • 1.8.3 North America Veterinary Pharmaceuticals Market Size and Prospect (2021-2032)
    • 1.8.4 Europe Veterinary Pharmaceuticals Market Size and Prospect (2021-2032)
    • 1.8.5 Asia-Pacific Veterinary Pharmaceuticals Market Size and Prospect (2021-2032)
    • 1.8.6 South America Veterinary Pharmaceuticals Market Size and Prospect (2021-2032)
    • 1.8.7 Middle East & Africa Veterinary Pharmaceuticals Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Zoetis
    • 2.1.1 Zoetis Details
    • 2.1.2 Zoetis Major Business
    • 2.1.3 Zoetis Veterinary Pharmaceuticals Product and Solutions
    • 2.1.4 Zoetis Veterinary Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Zoetis Recent Developments and Future Plans
  • 2.2 Elanco
    • 2.2.1 Elanco Details
    • 2.2.2 Elanco Major Business
    • 2.2.3 Elanco Veterinary Pharmaceuticals Product and Solutions
    • 2.2.4 Elanco Veterinary Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Elanco Recent Developments and Future Plans
  • 2.3 Boehringer Ingelheim
    • 2.3.1 Boehringer Ingelheim Details
    • 2.3.2 Boehringer Ingelheim Major Business
    • 2.3.3 Boehringer Ingelheim Veterinary Pharmaceuticals Product and Solutions
    • 2.3.4 Boehringer Ingelheim Veterinary Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Boehringer Ingelheim Recent Developments and Future Plans
  • 2.4 Merck
    • 2.4.1 Merck Details
    • 2.4.2 Merck Major Business
    • 2.4.3 Merck Veterinary Pharmaceuticals Product and Solutions
    • 2.4.4 Merck Veterinary Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Merck Recent Developments and Future Plans
  • 2.5 Virbac
    • 2.5.1 Virbac Details
    • 2.5.2 Virbac Major Business
    • 2.5.3 Virbac Veterinary Pharmaceuticals Product and Solutions
    • 2.5.4 Virbac Veterinary Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Virbac Recent Developments and Future Plans
  • 2.6 Ceva
    • 2.6.1 Ceva Details
    • 2.6.2 Ceva Major Business
    • 2.6.3 Ceva Veterinary Pharmaceuticals Product and Solutions
    • 2.6.4 Ceva Veterinary Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Ceva Recent Developments and Future Plans
  • 2.7 Vetoquinol
    • 2.7.1 Vetoquinol Details
    • 2.7.2 Vetoquinol Major Business
    • 2.7.3 Vetoquinol Veterinary Pharmaceuticals Product and Solutions
    • 2.7.4 Vetoquinol Veterinary Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Vetoquinol Recent Developments and Future Plans
  • 2.8 Dechra
    • 2.8.1 Dechra Details
    • 2.8.2 Dechra Major Business
    • 2.8.3 Dechra Veterinary Pharmaceuticals Product and Solutions
    • 2.8.4 Dechra Veterinary Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Dechra Recent Developments and Future Plans
  • 2.9 Norbrook
    • 2.9.1 Norbrook Details
    • 2.9.2 Norbrook Major Business
    • 2.9.3 Norbrook Veterinary Pharmaceuticals Product and Solutions
    • 2.9.4 Norbrook Veterinary Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Norbrook Recent Developments and Future Plans
  • 2.10 Phibro
    • 2.10.1 Phibro Details
    • 2.10.2 Phibro Major Business
    • 2.10.3 Phibro Veterinary Pharmaceuticals Product and Solutions
    • 2.10.4 Phibro Veterinary Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Phibro Recent Developments and Future Plans
  • 2.11 Huvepharma
    • 2.11.1 Huvepharma Details
    • 2.11.2 Huvepharma Major Business
    • 2.11.3 Huvepharma Veterinary Pharmaceuticals Product and Solutions
    • 2.11.4 Huvepharma Veterinary Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Huvepharma Recent Developments and Future Plans
  • 2.12 Hipra
    • 2.12.1 Hipra Details
    • 2.12.2 Hipra Major Business
    • 2.12.3 Hipra Veterinary Pharmaceuticals Product and Solutions
    • 2.12.4 Hipra Veterinary Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Hipra Recent Developments and Future Plans
  • 2.13 Ouro Fino Saude
    • 2.13.1 Ouro Fino Saude Details
    • 2.13.2 Ouro Fino Saude Major Business
    • 2.13.3 Ouro Fino Saude Veterinary Pharmaceuticals Product and Solutions
    • 2.13.4 Ouro Fino Saude Veterinary Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Ouro Fino Saude Recent Developments and Future Plans
  • 2.14 CAHIC
    • 2.14.1 CAHIC Details
    • 2.14.2 CAHIC Major Business
    • 2.14.3 CAHIC Veterinary Pharmaceuticals Product and Solutions
    • 2.14.4 CAHIC Veterinary Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 CAHIC Recent Developments and Future Plans
  • 2.15 Orion
    • 2.15.1 Orion Details
    • 2.15.2 Orion Major Business
    • 2.15.3 Orion Veterinary Pharmaceuticals Product and Solutions
    • 2.15.4 Orion Veterinary Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Orion Recent Developments and Future Plans
  • 2.16 Ringpu Biology
    • 2.16.1 Ringpu Biology Details
    • 2.16.2 Ringpu Biology Major Business
    • 2.16.3 Ringpu Biology Veterinary Pharmaceuticals Product and Solutions
    • 2.16.4 Ringpu Biology Veterinary Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Ringpu Biology Recent Developments and Future Plans
  • 2.17 Nippon Zenyaku Kogyo
    • 2.17.1 Nippon Zenyaku Kogyo Details
    • 2.17.2 Nippon Zenyaku Kogyo Major Business
    • 2.17.3 Nippon Zenyaku Kogyo Veterinary Pharmaceuticals Product and Solutions
    • 2.17.4 Nippon Zenyaku Kogyo Veterinary Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Nippon Zenyaku Kogyo Recent Developments and Future Plans
  • 2.18 Farmavet-Pasteur
    • 2.18.1 Farmavet-Pasteur Details
    • 2.18.2 Farmavet-Pasteur Major Business
    • 2.18.3 Farmavet-Pasteur Veterinary Pharmaceuticals Product and Solutions
    • 2.18.4 Farmavet-Pasteur Veterinary Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Farmavet-Pasteur Recent Developments and Future Plans
  • 2.19 Jinhe Bio
    • 2.19.1 Jinhe Bio Details
    • 2.19.2 Jinhe Bio Major Business
    • 2.19.3 Jinhe Bio Veterinary Pharmaceuticals Product and Solutions
    • 2.19.4 Jinhe Bio Veterinary Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Jinhe Bio Recent Developments and Future Plans
  • 2.20 Qianjiang Biochemical
    • 2.20.1 Qianjiang Biochemical Details
    • 2.20.2 Qianjiang Biochemical Major Business
    • 2.20.3 Qianjiang Biochemical Veterinary Pharmaceuticals Product and Solutions
    • 2.20.4 Qianjiang Biochemical Veterinary Pharmaceuticals Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 Qianjiang Biochemical Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Veterinary Pharmaceuticals Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Veterinary Pharmaceuticals by Company Revenue
    • 3.2.2 Top 3 Veterinary Pharmaceuticals Players Market Share in 2025
    • 3.2.3 Top 6 Veterinary Pharmaceuticals Players Market Share in 2025
  • 3.3 Veterinary Pharmaceuticals Market: Overall Company Footprint Analysis
    • 3.3.1 Veterinary Pharmaceuticals Market: Region Footprint
    • 3.3.2 Veterinary Pharmaceuticals Market: Company Product Type Footprint
    • 3.3.3 Veterinary Pharmaceuticals Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Veterinary Pharmaceuticals Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Veterinary Pharmaceuticals Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Veterinary Pharmaceuticals Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Veterinary Pharmaceuticals Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Veterinary Pharmaceuticals Consumption Value by Type (2021-2032)
  • 6.2 North America Veterinary Pharmaceuticals Market Size by Application (2021-2032)
  • 6.3 North America Veterinary Pharmaceuticals Market Size by Country
    • 6.3.1 North America Veterinary Pharmaceuticals Consumption Value by Country (2021-2032)
    • 6.3.2 United States Veterinary Pharmaceuticals Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Veterinary Pharmaceuticals Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Veterinary Pharmaceuticals Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Veterinary Pharmaceuticals Consumption Value by Type (2021-2032)
  • 7.2 Europe Veterinary Pharmaceuticals Consumption Value by Application (2021-2032)
  • 7.3 Europe Veterinary Pharmaceuticals Market Size by Country
    • 7.3.1 Europe Veterinary Pharmaceuticals Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Veterinary Pharmaceuticals Market Size and Forecast (2021-2032)
    • 7.3.3 France Veterinary Pharmaceuticals Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Veterinary Pharmaceuticals Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Veterinary Pharmaceuticals Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Veterinary Pharmaceuticals Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Veterinary Pharmaceuticals Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Veterinary Pharmaceuticals Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Veterinary Pharmaceuticals Market Size by Region
    • 8.3.1 Asia-Pacific Veterinary Pharmaceuticals Consumption Value by Region (2021-2032)
    • 8.3.2 China Veterinary Pharmaceuticals Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Veterinary Pharmaceuticals Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Veterinary Pharmaceuticals Market Size and Forecast (2021-2032)
    • 8.3.5 India Veterinary Pharmaceuticals Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Veterinary Pharmaceuticals Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Veterinary Pharmaceuticals Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Veterinary Pharmaceuticals Consumption Value by Type (2021-2032)
  • 9.2 South America Veterinary Pharmaceuticals Consumption Value by Application (2021-2032)
  • 9.3 South America Veterinary Pharmaceuticals Market Size by Country
    • 9.3.1 South America Veterinary Pharmaceuticals Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Veterinary Pharmaceuticals Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Veterinary Pharmaceuticals Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Veterinary Pharmaceuticals Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Veterinary Pharmaceuticals Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Veterinary Pharmaceuticals Market Size by Country
    • 10.3.1 Middle East & Africa Veterinary Pharmaceuticals Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Veterinary Pharmaceuticals Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Veterinary Pharmaceuticals Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Veterinary Pharmaceuticals Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Veterinary Pharmaceuticals Market Drivers
  • 11.2 Veterinary Pharmaceuticals Market Restraints
  • 11.3 Veterinary Pharmaceuticals Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Veterinary Pharmaceuticals Industry Chain
  • 12.2 Veterinary Pharmaceuticals Upstream Analysis
  • 12.3 Veterinary Pharmaceuticals Midstream Analysis
  • 12.4 Veterinary Pharmaceuticals Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Veterinary Pharmaceuticals market size was valued at US$ 28487 million in 2025 and is forecast to a readjusted size of US$ 40922 million by 2032 with a CAGR of 5.4% during review period.
    Veterinary pharmaceuticals are medicines and biologics used to prevent and treat diseases in animals across companion and food-producing species. The category spans preventive biologics (e.g., vaccines) and therapeutic products such as antiparasitics, anti-infectives, anti-inflammatory/pain management drugs, dermatology/allergy therapies, and reproduction/metabolic care. Supply and use are heavily shaped by regulatory approvals, food-safety residue controls for livestock, and veterinary oversight—raising the bar for efficacy, safety, and responsible use.
    Growth is underpinned by two structural forces: first, “humanization” of companion-animal care is lifting willingness to pay and normalizing chronic disease management (e.g., dermatology/allergy, OA pain, cardio-renal and metabolic care), which supports higher-value prescription therapeutics and preventive routines. Second, continued intensification of livestock/aquaculture systems—combined with outbreak risk and trade-related health requirements—drives sustained investment in vaccines, biosecurity, and targeted treatments to protect productivity and supply stability; WOAH also highlights vaccination and biosecurity as key levers to prevent disease and reduce reliance on antimicrobials.
    This report is a detailed and comprehensive analysis for global Veterinary Pharmaceuticals market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Veterinary Pharmaceuticals market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Veterinary Pharmaceuticals market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Veterinary Pharmaceuticals market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Veterinary Pharmaceuticals market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Veterinary Pharmaceuticals
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Veterinary Pharmaceuticals market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Elanco, Boehringer Ingelheim, Merck, Virbac, Ceva, Vetoquinol, Dechra, Norbrook, Phibro, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Veterinary Pharmaceuticals market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Anti-Infectives
    Anti-Inflammatory
    Parasiticides
    Analgesics
    Sedatives
    Others
    Market segment by Route
    Oral
    Injection
    Market segment by Control Level
    Prescription-only
    OTC
    Market segment by Application
    Companion Animals
    Cattle
    Poultry
    Swine
    Others
    Market segment by players, this report covers
    Zoetis
    Elanco
    Boehringer Ingelheim
    Merck
    Virbac
    Ceva
    Vetoquinol
    Dechra
    Norbrook
    Phibro
    Huvepharma
    Hipra
    Ouro Fino Saude
    CAHIC
    Orion
    Ringpu Biology
    Nippon Zenyaku Kogyo
    Farmavet-Pasteur
    Jinhe Bio
    Qianjiang Biochemical
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Veterinary Pharmaceuticals product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Veterinary Pharmaceuticals, with revenue, gross margin, and global market share of Veterinary Pharmaceuticals from 2021 to 2026.
    Chapter 3, the Veterinary Pharmaceuticals competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Veterinary Pharmaceuticals market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Veterinary Pharmaceuticals.
    Chapter 13, to describe Veterinary Pharmaceuticals research findings and conclusion.

    Buy now